Literature DB >> 7682538

Epstein-Barr virus and gastric cancer: data and unanswered questions.

L Leoncini1, C Vindigni, T Megha, I Funtò, L Pacenti, M Musarò, A Renieri, M Seri, J Anagnostopoulos, P Tosi.   

Abstract

Sixty-five unselected cases of gastric cancer have been analysed for EBV DNA by polymerase chain reaction, in situ hybridization and immunohistochemistry for CD21 antigen expression. Four cases were found EBV-positive by PCR, while ISH yielded positive results in 3 of these cases, demonstrating EBV in the nuclei of cancerous cells. CD21 antigen was expressed in cancerous cells in all 3 ISH-positive cases. All the EBV-positive cancers of the present series were poorly to moderately differentiated adenocarcinomas with prominent lymphoid infiltration. These results are discussed also on the basis of the literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682538     DOI: 10.1002/ijc.2910530605

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

Review 1.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

2.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

3.  Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas.

Authors:  Maria D Begnami; Andre L Montagnini; Andre L Vettore; Sueli Nonogaki; Mariana Brait; Alex Y Simoes-Sato; Andrea Q A Seixas; Fernando A Soares
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice.

Authors:  Y Iwasaki; J M Chong; Y Hayashi; R Ikeno; K Arai; M Kitamura; M Koike; K Hirai; M Fukayama
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa.

Authors:  S Shousha; Y A Luqmani
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

6.  Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression.

Authors:  J Nishikawa; S Imai; T Oda; T Kojima; K Okita; K Takada
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.

Authors:  S Imai; S Koizumi; M Sugiura; M Tokunaga; Y Uemura; N Yamamoto; S Tanaka; E Sato; T Osato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Authors:  Q N Vo; J Geradts; M L Gulley; D A Boudreau; J C Bravo; B G Schneider
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

9.  Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom.

Authors:  D E Burgess; C B Woodman; K J Flavell; D C Rowlands; J Crocker; K Scott; J P Biddulph; L S Young; P G Murray
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

10.  Epstein-Barr virus-associated gastric carcinoma in Brazil: comparison between in situ hybridization and polymerase chain reaction detection.

Authors:  Marcos Antonio Pereira de Lima; Márcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês de Moura Campos Pardini; Adriana Camargo Ferrasi; Silvia Helena Barem Rabenhorst
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.